ACT vs CBT Trial for Psychological Distress in HIV/AIDS Patients
A randomized controlled trial is underway comparing Acceptance and Commitment Therapy and Cognitive Behavioral Therapy in HIV/AIDS patients.
Phase III
Psychiatry / Mental Health
Status
Active
Sponsor
Pfizer
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This trial is significant as it explores psychological interventions for HIV/AIDS patients, a population that often faces stigma and mental health challenges. The outcomes could reshape treatment protocols and influence portfolio strategies for companies in the mental health space.
Recommended action
Humanexa recommends Monitor: Monitoring is recommended to track the trial's outcomes, which could have implications for treatment strategies and competitive dynamics in the mental health therapy market.
Analysis
Monitor outcomes related to depression, anxiety, and stigma, as well as the overall effectiveness of ACT vs CBT in this population.
Related companies & assets
Companies
Assets
Sources & Humanexa intelligence
Source links
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.